FDA Drug Application (020584) for LODINE XL by WYETH PHARMS INC

Back to FDA Applications sponsored by WYETH PHARMS INC

Application Number020584
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage400MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLODINE XL
Active IngredientETODOLAC

Active IngredientCount
List of drugs with Active Ingredient ETODOLAC3


Back to FDA Applications sponsored by WYETH PHARMS INC